A Preview Of CytoSorbents's Earnings
Portfolio Pulse from Benzinga Insights
CytoSorbents (NASDAQ:CTSO) is scheduled to release its quarterly earnings report on March 14, 2024, with an estimated EPS of $-0.14. Investors are hopeful for a beat on this estimate and positive guidance for the next quarter. Despite past earnings misses, the stock price has shown varied responses. Currently, shares are trading at $1.0, marking a 68.81% decline over the last 52 weeks, indicating long-term shareholder dissatisfaction.

March 13, 2024 | 4:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
CytoSorbents is anticipated to report quarterly earnings with an EPS of $-0.14. Positive guidance and beating estimates could influence stock performance.
Given the anticipation of beating the EPS estimate and providing positive guidance, there's potential for a positive short-term impact on CTSO's stock price. Historically, the stock has shown mixed reactions to earnings reports, but positive guidance could outweigh past performance concerns. However, the confidence in this analysis is moderated by the stock's recent negative trend, indicating that broader market or company-specific factors could also play a significant role.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100